Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial.
Full text not available from this repository.| Item Type: | Article |
|---|---|
| Status: | Published |
| Official URL: | https://doi.org/10.1136/bmjopen-2018-026627 |
| Journal or Publication Title: | BMJ Open |
| Volume: | 9 |
| Number: | 1 |
| Page Range: | e026627 |
| Date: | 2019 |
| Divisions: | Cardio Genomics Molecular Cardiology |
| Depositing User: | General Admin |
| Identification Number: | 10.1136/bmjopen-2018-026627 |
| ISSN: | 2044-6055 |
| Date Deposited: | 17 Dec 2020 03:28 |
| Abstract: | Introduction: Genetic testing for hypertrophic cardiomyopathy (HCM) in the era of genomics brings unique challenges for genetic counselling. The number of genes routinely included in an HCM gene panel has increased markedly, many with minimal if any robust evidence of gene-disease association. Subsequently, there is a greater chance of uncertain genetic findings. The responsibility of communicating this information with at-risk relatives lies with the index case (proband). We have developed a communication aid to assist with the delivery of genetic results to the proband. We have previously shown the aid is feasible and acceptable and have now developed a study protocol for a randomised controlled trial of a genetic counsellor-led intervention incorporating the communication aid. Methods and analysis: This is a prospective randomised controlled trial. We will investigate the impact of a genetic counsellor-led intervention to return proband genetic results using a custom-designed communication aid. We aim to improve knowledge and empowerment. The primary outcome of this trial is the ability and confidence of the proband to communicate genetic results to at-risk relatives. Secondary outcomes will assess genetic knowledge, satisfaction with services, outcomes from genetic counselling and psychological adaptation to genetic information. Ethics and dissemination: This study has been approved by and is in strict accordance with the Sydney Local Health District Ethics Review Committee (X16-0030; 22/01/2016; version 1). Results from this trial will be prepared as a manuscript and submitted to peer-reviewed journals for publication as well as submission for presentation at national and international meetings. Trial registration number: ACTRN12617000706370. Keywords: Cardiomyopathy; Genetics. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| Creators: | Creators Email Burns, Charlotte UNSPECIFIED Yeates, Laura UNSPECIFIED Semsarian, Christopher UNSPECIFIED Ingles, Jodie UNSPECIFIED |
| Last Modified: | 17 Dec 2020 03:28 |
| URI: | https://eprints.centenary.org.au/id/eprint/258 |
Actions (login required)
 |
View Item |
